Seizure after surgical treatment of chronic subdural hematoma-Associated factors and effect on outcome.

chronic subdural hematoma clinical outcome depressed brain volume epilepsy hematoma recurrence seizure

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 24 06 2022
accepted: 15 08 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 27 9 2022
Statut: epublish

Résumé

Chronic subdural hematoma (cSDH) is becoming more prevalent due to population aging and the increasing use of antithrombotic drugs. Postoperative seizure in cSDH have a negative effect on outcome, and there currently no consensus regarding prophylactic anti-epileptic drug (AED) treatment. The objective of this study was to evaluate predisposing and triggering factors associated with postoperative epileptic seizure in patients with cSDH. All patients, who were surgically treated for cSDH in a single tertiary care center between 2015 and 2019, were considered for inclusion. Relevant patient- and hematoma-specific characteristics were retrospectively extracted from hospital records. Paroxysmal events categorized by the treating physician as suspected postoperative seizures were noted. The clinical outcome was extracted from the last available follow-up visit and classified according to the Glasgow outcome scale (GOS). Of the included 349 patients, 54 (15.5%) developed suspected postoperative epileptic complications in the form of early seizure (≤ 7 days) in 11 patients (3.2%) and late seizure (>7 days) in 43 patients (12.3%). In the logistic regression analysis, solely depressed brain volume (supratentorial volume (ml) not filled with re-expanded brain) was independently associated with postoperative seizure (odds ratio [ Larger postoperative depressed brain volume was the only factor independently associated with suspected postoperative seizure, and it could help identify a subgroup of patients with higher susceptibility to epileptic events. Based on our data, no formal recommendation can be made regarding the prophylactic use of anti-epileptic drugs. Nevertheless, the relative safety of new generation AEDs and the detrimental effect of postoperative seizure on outcome may justify its use in a selected patient population.

Identifiants

pubmed: 36158969
doi: 10.3389/fneur.2022.977329
pmc: PMC9493299
doi:

Types de publication

Journal Article

Langues

eng

Pagination

977329

Informations de copyright

Copyright © 2022 Hamou, Alzaiyani, Rossmann, Pjontek, Kremer, Zaytoun, Ridwan, Clusmann, Hoellig and Veldeman.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurosurg. 2021 Sep 10;136(4):1186-1193
pubmed: 34507291
Neurocrit Care. 2021 Oct;35(Suppl 2):105-111
pubmed: 34617253
Seizure. 2017 Feb;45:28-35
pubmed: 27914224
Neurosurgery. 2020 Jul 1;87(1):96-103
pubmed: 31555809
Acta Neurochir (Wien). 1986;79(2-4):100-6
pubmed: 3962738
World Neurosurg. 2019 Dec;132:e716-e721
pubmed: 31421304
Cochrane Database Syst Rev. 2013 Jun 06;(6):CD004893
pubmed: 23744552
Epilepsia. 2022 Jun;63(6):1443-1474
pubmed: 35503725
J Clin Neurosci. 2004 Sep;11(7):706-9
pubmed: 15337129
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Surg Neurol. 2004 Jun;61(6):523-7; discussion 527-8
pubmed: 15165784
Neurosurgery. 2019 Nov 1;85(5):E825-E834
pubmed: 31194877
Neurochirurgie. 2012 Aug;58(4):230-4
pubmed: 22626817
J Neurosurg. 2001 Aug;95(2):256-62
pubmed: 11780895
J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1231-3
pubmed: 8229039
Cureus. 2020 Sep 20;12(9):e10549
pubmed: 33101797
J Neurosurg. 2009 Dec;111(6):1257-62
pubmed: 19558304
World Neurosurg. 2020 Jun;138:e426-e436
pubmed: 32147547
QJM. 2017 Jun 01;110(6):375-378
pubmed: 28069915
Neurocrit Care. 2020 Feb;32(1):306-310
pubmed: 31338747
Can J Neurol Sci. 2021 Jan;48(1):31-37
pubmed: 32631474
J Neurosurg. 2020 Mar 27;134(3):1294-1302
pubmed: 32217801
World Neurosurg. 2020 Feb;134:240-263
pubmed: 31682989
Neurosurg Rev. 2022 Aug;45(4):2777-2786
pubmed: 35461433
Neurosurg Rev. 2021 Aug;44(4):2069-2077
pubmed: 32910368
Sci Rep. 2020 Jan 24;10(1):1145
pubmed: 31980723
Dtsch Arztebl Int. 2022 Mar 25;119(12):208-213
pubmed: 35236548
J Neurosurg. 2019 Jan 18;:1-5
pubmed: 30660118
J Neurol. 2022 Jun;269(6):3180-3188
pubmed: 34999957
J Neurosurg. 2018 Jan;128(1):222-228
pubmed: 28156246
Neurocrit Care. 2011 Apr;14(2):253-9
pubmed: 21286854

Auteurs

Hussam Hamou (H)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Mohammed Alzaiyani (M)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Tobias Rossmann (T)

Department of Neurosurgery, Neuromed Campus, Kepler University Hospital, Linz, Austria.

Rastislav Pjontek (R)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Benedikt Kremer (B)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Hasan Zaytoun (H)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Hani Ridwan (H)

Department of Diagnostic and Interventional Neuroradiology, RWTH Aachen University, Aachen, Germany.

Hans Clusmann (H)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Anke Hoellig (A)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Michael Veldeman (M)

Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.

Classifications MeSH